HDAC9 and head and neck squamous cell carcinoma: In addition, given the hypothesis that HDAC inhibition likely induces chromatin relaxation where platinum-based chemotherapy or radiation can induce DNA-damage more potently, vorinostat was evaluated in a phase 1 trial in combination with concurrent chemoradiation therapy in the treatment of advanced staged HNSCC [21].